Con, D., & Srinivasan, A. (2024). Letter: Comparing first‐line infliximab and vedolizumab for ulcerative colitis—it depends on how you use the drug. Alimentary Pharmacology & Therapeutics, 59(1), 140. https://doi.org/10.1111/apt.17770
Chicago Style (17th ed.) CitationCon, Danny, and Ashish Srinivasan. "Letter: Comparing First‐line Infliximab and Vedolizumab for Ulcerative Colitis—it Depends on How You Use the Drug." Alimentary Pharmacology & Therapeutics 59, no. 1 (2024): 140. https://doi.org/10.1111/apt.17770.
MLA (9th ed.) CitationCon, Danny, and Ashish Srinivasan. "Letter: Comparing First‐line Infliximab and Vedolizumab for Ulcerative Colitis—it Depends on How You Use the Drug." Alimentary Pharmacology & Therapeutics, vol. 59, no. 1, 2024, p. 140, https://doi.org/10.1111/apt.17770.